Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00341263 · ClinicalTrials.gov registry record
Maternal and Umbilical Cord Hormone Concentrations in Twin and Singleton Pregnancies
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 111
- Enrollment target
NCT00341263: Completed study, sponsored by National Cancer Institute (NCI).
NCT00341263 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 111 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00341263 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 111 participants
- Enrollment target
Study Summary
This study will examine levels of hormones, such as estrogen and testosterone, in maternal and umbilical cord blood to compare hormones between mothers who are having twins and mothers who are having one baby. It will investigate whether hormone levels in twin versus singleton pregnancies influence the babies' risk of developing breast, prostate, and testicular cancers later in life. Pregnant women 18 years of age and older who do not have preeclampsia, chronic hypertension, pre-pregnancy or gestational diabetes, thyroid disease, or other major pregnancy complications are eligible for this study. Participants will be recruited from the obstetrics and gynecology practice at the Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire. Participants will have a blood sample drawn from their arm during their third trimester prenatal visit and again when they are admitted to the hospital for delivery. After the baby is born, a blood sample will be collected from the cut umbilical cord. Information about the pregnancy and delivery will be collected from the mother's medical chart, and information about the baby's size will be obtained from the baby's medical chart.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 111 participants |
| Start Date | 2003-11-21 |
| Est. Completion | 2020-02-19 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00341263
The ClinicalTrials.gov registry entry for NCT00341263 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 111 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00341263 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00341263 about?
NCT00341263 is a clinical study titled "Maternal and Umbilical Cord Hormone Concentrations in Twin and Singleton Pregnancies". This study will examine levels of hormones, such as estrogen and testosterone, in maternal and umbilical cord blood to compare hormones between mothers who are having twins and mothers who are having one baby. It will investigate whether hormone levels in twin versus singleton pregnancies influence ...
What is the current status of trial NCT00341263?
This trial is currently completed. The enrollment target is 111 participants. The study started on 2003-11-21. Estimated completion is 2020-02-19.
Who is sponsoring clinical trial NCT00341263?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.